Terms: = Endocrine gland cancer AND GPC3, OCI-5, 2719, ENSG00000147257, SGBS, SGB, DGSX, SDYS, P51654, AC002420_1, SGBS1 AND Treatment
14 results:
1. Administration of a glypican-3 peptide increases the infiltration and cytotoxicity of CD8
Zhao J; Qin L; He G; Xie T; Hu G; Wang F; Zhong H; Zhu J; Xu Y
Cancer Med; 2023 Dec; 12(23):21293-21307. PubMed ID: 37986544
[TBL] [Abstract] [Full Text] [Related]
2. A novel risk model based on the correlation between the expression of basement membrane genes and immune infiltration to predict the invasiveness of pituitary adenomas.
Chen Z; Sun X; Kang Y; Zhang J; Jia F; Liu X; Zhu H
Front Endocrinol (Lausanne); 2022; 13():1079777. PubMed ID: 36686480
[TBL] [Abstract] [Full Text] [Related]
3. IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin.
Pang N; Shi J; Qin L; Chen A; Tang Y; Yang H; Huang Y; Wu Q; Li X; He B; Li T; Liang B; Zhang J; Cao B; Liu M; Feng Y; Ye X; Chen X; Wang L; Tian Y; Li H; Li J; Hu H; He J; Hu Y; Zhi C; Tang Z; Gong Y; Xu F; Xu L; Fan W; Zhao M; Chen D; Lian H; Yang L; Li P; Zhang Z
J Hematol Oncol; 2021 Jul; 14(1):118. PubMed ID: 34325726
[TBL] [Abstract] [Full Text] [Related]
4. An ectopic adrenocortical oncocytic adenoma in the liver highly mimicking hepatocellular carcinoma: case report and literature review.
Chen J; Wan X; Lu Y; Wang W; Zhao D; Lu Z; Mao Y; Chen J
Diagn Pathol; 2021 Jul; 16(1):58. PubMed ID: 34218806
[TBL] [Abstract] [Full Text] [Related]
5. Rapid tumor vaccine using Toll-like receptor-activated ovarian cancer ascites monocytes.
Adams SF; Grimm AJ; Chiang CL; Mookerjee A; Flies D; Jean S; McCann GA; Michaux J; Pak H; Huber F; Neal C; Dangaj D; Bassani-Sternberg M; Rusakiewicz S; Facciabene A; Coukos G; Gimotty PA; Kandalaft LE
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32817208
[TBL] [Abstract] [Full Text] [Related]
6. Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cells.
Ueda T; Kumagai A; Iriguchi S; Yasui Y; Miyasaka T; Nakagoshi K; Nakane K; Saito K; Takahashi M; Sasaki A; Yoshida S; Takasu N; Seno H; Uemura Y; Tamada K; Nakatsura T; Kaneko S
Cancer Sci; 2020 May; 111(5):1478-1490. PubMed ID: 32133731
[TBL] [Abstract] [Full Text] [Related]
7. Alpha-fetoprotein-producing ovarian clear cell adenocarcinoma with fetal gut differentiation: a rare case report and literature review.
Chao WT; Liu CH; Lai CR; Chen YJ; Chuang CM; Wang PH
J Ovarian Res; 2018 Jun; 11(1):52. PubMed ID: 29933751
[TBL] [Abstract] [Full Text] [Related]
8. [cancer peptide vaccine targeted glypican-3 antigen].
Nakatsura T
Nihon Rinsho; 2017 Feb; 75(2):257-262. PubMed ID: 30562861
[TBL] [Abstract] [Full Text] [Related]
9. [Diagnostic value of immunohistochemistry and FISH for chromosome 12p in type Ⅱ testicular germ cell tumors].
Shen Q; Rao Q; Yu B; Xia QY; Bao W; Lu ZF; Shi QL; Zhou XJ
Zhonghua Nan Ke Xue; 2016 Aug; 22(8):692-697. PubMed ID: 29019224
[TBL] [Abstract] [Full Text] [Related]
10. Significant clinical response of progressive recurrent ovarian clear cell carcinoma to glypican-3-derived peptide vaccine therapy: two case reports.
Suzuki S; Shibata K; Kikkawa F; Nakatsura T
Hum Vaccin Immunother; 2014; 10(2):338-43. PubMed ID: 24252799
[TBL] [Abstract] [Full Text] [Related]
11. Glypican-3 expression predicts poor clinical outcome of patients with early-stage clear cell carcinoma of the ovary.
Umezu T; Shibata K; Kajiyama H; Yamamoto E; Nawa A; Kikkawa F
J Clin Pathol; 2010 Nov; 63(11):962-6. PubMed ID: 20972242
[TBL] [Abstract] [Full Text] [Related]
12. Gene expression profiling of a clonal isolate of oxaliplatin-resistant ovarian carcinoma cell line A2780/C10.
Varma RR; Hector SM; Clark K; Greco WR; Hawthorn L; Pendyala L
Oncol Rep; 2005 Oct; 14(4):925-32. PubMed ID: 16142353
[TBL] [Abstract] [Full Text] [Related]
13. [Surgical treatment of ovarian malignant tumors metastasized to the gastro-intestinal tract: a report of 131 cases].
Peng Z; Pan X; Liu H
Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):142-4. PubMed ID: 11776859
[TBL] [Abstract] [Full Text] [Related]
14. Frequent silencing of the gpc3 gene in ovarian cancer cell lines.
Lin H; Huber R; Schlessinger D; Morin PJ
Cancer Res; 1999 Feb; 59(4):807-10. PubMed ID: 10029067
[TBL] [Abstract] [Full Text] [Related]